Photo from wikipedia
Key Points Question Did screening for breast and lung cancer return to expected rates after the initial phase of the COVID-19 pandemic in 2020? Findings In this cohort study of… Click to show full abstract
Key Points Question Did screening for breast and lung cancer return to expected rates after the initial phase of the COVID-19 pandemic in 2020? Findings In this cohort study of Medicare enrollees from the beginning of the COVID-19 pandemic in March 2020 through July 2022, both mammography and low-dose computed tomographic screening fell below expected rates, coincident with increases in national COVID-19 infection rates. Meaning Interference with cancer screening by periodic surges in COVID-19 infections is a continuing problem.
Keywords:
lung cancer;
covid pandemic;
breast lung;
cancer screening;
medicare enrollees;
cancer
Journal Title: JAMA Network Open
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: JAMA Network Open
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!